N/A
Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical castration is often considered the treatment of choice as it is psychologically better tolerated. We report our experience of one patient undergoing treatment with Gn-RH agonist who developed an early resistance to the administered drug, with serum testosterone levels within the range of normality.
Gn-RH antagonist possible response, after Gn-RH agonist failure in a man with metastatic prostate cancer / Rocco, Bernardo Maria Cesare; Ferrari, M; Scardino, E; Matei, Dv; Verweij, F; Varela, R; De Cobelli, O.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 25:1B(2005), pp. 577-578.
Data di pubblicazione: | 2005 |
Titolo: | Gn-RH antagonist possible response, after Gn-RH agonist failure in a man with metastatic prostate cancer |
Autore/i: | Rocco, Bernardo Maria Cesare; Ferrari, M; Scardino, E; Matei, Dv; Verweij, F; Varela, R; De Cobelli, O. |
Autore/i UNIMORE: | |
Rivista: | |
Volume: | 25 |
Fascicolo: | 1B |
Pagina iniziale: | 577 |
Pagina finale: | 578 |
Codice identificativo ISI: | WOS:000228138000029 |
Codice identificativo Scopus: | 2-s2.0-16344378051 |
Codice identificativo Pubmed: | 15816630 |
Citazione: | Gn-RH antagonist possible response, after Gn-RH agonist failure in a man with metastatic prostate cancer / Rocco, Bernardo Maria Cesare; Ferrari, M; Scardino, E; Matei, Dv; Verweij, F; Varela, R; De Cobelli, O.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 25:1B(2005), pp. 577-578. |
Tipologia | Articolo su rivista |
File in questo prodotto:

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris